Published in Eur J Gastroenterol Hepatol on December 01, 1999
Tn5-induced mutations affecting virulence factors of Bordetella pertussis. Infect Immun (1983) 8.49
Virulence factors of Bordetella pertussis. Annu Rev Microbiol (1986) 6.41
Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids. Proc Natl Acad Sci U S A (1984) 6.01
Genetic analysis of phase change in Bordetella pertussis. Infect Immun (1984) 5.03
Pertussis toxin and extracytoplasmic adenylate cyclase as virulence factors of Bordetella pertussis. J Infect Dis (1984) 3.48
Mercury and organomercurial resistances determined by plasmids in Staphylococcus aureus. J Bacteriol (1977) 3.29
Invasion of HeLa 229 cells by virulent Bordetella pertussis. Infect Immun (1989) 3.27
Cloning of monoclonal autoantibodies to epitopes of oxidized lipoproteins from apolipoprotein E-deficient mice. Demonstration of epitopes of oxidized low density lipoprotein in human plasma. J Clin Invest (1996) 3.10
Genetic analysis of a region of the Bordetella pertussis chromosome encoding filamentous hemagglutinin and the pleiotropic regulatory locus vir. J Bacteriol (1988) 2.96
Cation transport alteration associated with plasmid-determined resistance to cadmium in Staphylococcus aureus. Antimicrob Agents Chemother (1978) 2.39
Cloning and sequencing of a Bordetella pertussis serum resistance locus. Infect Immun (1994) 2.39
Transposon A-generated mutations in the mercuric resistance genes of plasmid R100-1. J Bacteriol (1979) 2.33
Oxidation of human low density lipoprotein results in derivatization of lysine residues of apolipoprotein B by lipid peroxide decomposition products. J Biol Chem (1987) 2.32
Obstacles to residents' conducting research and predictors of publication. Acad Med (2001) 2.25
Radiofrequency ablation of porcine liver in vivo: effects of blood flow and treatment time on lesion size. Ann Surg (1998) 2.19
Diffusion tensor MR imaging and fiber tractography: theoretic underpinnings. AJNR Am J Neuroradiol (2008) 2.18
Environmental regulation of expression of virulence determinants in Bordetella pertussis. J Bacteriol (1989) 2.11
Essential role of phospholipase A2 activity in endothelial cell-induced modification of low density lipoprotein. Proc Natl Acad Sci U S A (1985) 2.11
Diffusion tensor MR imaging and fiber tractography: technical considerations. AJNR Am J Neuroradiol (2008) 1.95
Bordetella pertussis adenylate cyclase toxin and hemolytic activities require a second gene, cyaC, for activation. J Bacteriol (1991) 1.90
Adenylate cyclase toxin is critical for colonization and pertussis toxin is critical for lethal infection by Bordetella pertussis in infant mice. Infect Immun (1990) 1.87
Decrease in reactive amino groups during oxidation or endothelial cell modification of LDL. Correlation with changes in receptor-mediated catabolism. Arteriosclerosis (1987) 1.80
Properties of the earliest clonogenic hemopoietic precursors to appear in the developing murine yolk sac. Proc Natl Acad Sci U S A (1986) 1.80
Mercury and organomercurial resistances determined by plasmids in Pseudomonas. J Bacteriol (1977) 1.75
Pten (phosphatase and tensin homologue gene) haploinsufficiency promotes insulin hypersensitivity. Diabetologia (2006) 1.72
Reactive nitrogen intermediates promote low density lipoprotein oxidation in human atherosclerotic intima. J Biol Chem (1997) 1.71
Receptor-mediated catabolism of low density lipoprotein in man. Quantitation using glucosylated low density lipoprotein. J Clin Invest (1983) 1.68
Transposon insertion and subsequent donor formation promoted by Tn501 in Bordetella pertussis. J Bacteriol (1983) 1.65
Indocyanine green clearance as a predictor of successful hepatic resection in cirrhotic patients. Am J Surg (1992) 1.63
Review article: possible beneficial effects of coffee on liver disease and function. Aliment Pharmacol Ther (2007) 1.61
Immortalized hemopoietic cells with stem cell properties. Immunity (1994) 1.55
Bordetella pertussis virulence factors affect phagocytosis by human neutrophils. Infect Immun (2000) 1.52
Inhibition of monocyte oxidative responses by Bordetella pertussis adenylate cyclase toxin. J Immunol (1987) 1.45
At what price, glory? Severe cholestasis and acute renal failure in an athlete abusing stanozolol. CMAJ (1994) 1.45
Exploring differences in response to treatment with peginterferon alpha 2a (40kD) and ribavirin in chronic hepatitis C between genotypes 2 and 3. J Viral Hepat (2008) 1.45
Retention of a cis Golgi protein requires polar residues on one face of a predicted alpha-helix in the transmembrane domain. Mol Biol Cell (1993) 1.44
Bladder outflow tract obstruction and urinary retention from benign prostatic hypertrophy treated by balloon dilatation. Br J Urol (1989) 1.43
A comparison of pipecuronium with pancuronium on haemodynamic variables and plasma catecholamines in coronary artery bypass patients. Can J Anaesth (1994) 1.42
Fluorescent labels influence phagocytosis of Bordetella pertussis by human neutrophils. Infect Immun (1999) 1.41
Plasmid transfer to Bordetella pertussis: conjugation and transformation. J Bacteriol (1982) 1.40
Analysis of causes of death in liver transplant recipients who survived more than 3 years. Liver Transpl (2001) 1.40
Primary biliary cirrhosis and inflammatory bowel disease. Am J Gastroenterol (1993) 1.39
Immunogenicity of homologous low density lipoprotein after methylation, ethylation, acetylation, or carbamylation: generation of antibodies specific for derivatized lysine. J Lipid Res (1984) 1.39
Hemoglobin switching during murine embryonic development: evidence for two populations of embryonic erythropoietic progenitor cells. Blood (1986) 1.39
Retinoids inhibit interleukin-12 production in macrophages through physical associations of retinoid X receptor and NFkappaB. J Biol Chem (1999) 1.38
Retrovirus-mediated transfer and expression of the interleukin-3 gene in mouse hematopoietic cells result in a myeloproliferative disorder. Mol Cell Biol (1989) 1.34
Nonenzymatic glucosylation of homologous low density lipoprotein and albumin renders them immunogenic in the guinea pig. Proc Natl Acad Sci U S A (1983) 1.32
Mullerian duct anomalies: from diagnosis to intervention. Br J Radiol (2009) 1.32
Radiofrequency ablation followed by resection of malignant liver tumors. Am J Surg (1999) 1.30
Serum resistance in bvg-regulated mutants of Bordetella pertussis. FEMS Microbiol Lett (1998) 1.30
Pathophysiology of apolipoprotein E deficiency in mice: relevance to apo E-related disorders in humans. FASEB J (2001) 1.29
A 23-kilodalton protein, distinct from BvgA, expressed by virulent Bordetella pertussis binds to the promoter region of vir-regulated toxin genes. Infect Immun (1991) 1.29
Management of duodenal diverticula. Can J Surg (1982) 1.26
Characterization of the dermonecrotic toxin in members of the genus Bordetella. Infect Immun (1994) 1.25
BrkA protein of Bordetella pertussis inhibits the classical pathway of complement after C1 deposition. Infect Immun (2001) 1.24
Peginterferon alfa-2a (40KD) plus ribavirin in chronic hepatitis C patients who failed previous interferon therapy. Gut (2006) 1.22
Cryptogenic organizing pneumonia. A report of 25 cases and a review of the literature. Medicine (Baltimore) (1995) 1.21
Retroviral transfer and expression of the interleukin-3 gene in hemopoietic cells. Genes Dev (1987) 1.21
High-efficiency identification of genes by functional analysis from a retroviral cDNA expression library. J Virol (1994) 1.21
Interferon-based combination anti-viral therapy for hepatitis C virus after liver transplantation: a review and quantitative analysis. Am J Transplant (2006) 1.20
Diffusion tensor MR imaging tractography of the pyramidal tracts correlates with clinical motor function in children with congenital hemiparesis. AJNR Am J Neuroradiol (2007) 1.17
A review of selective salpingography and fallopian tube catheterization. Radiographics (2001) 1.15
Treatment of type II endoleaks with Onyx. J Vasc Interv Radiol (2001) 1.15
Case report: multiple hepatic and pulmonary haemangioblastomas--a new manifestation of von Hippel-Lindau disease. Clin Radiol (1992) 1.13
Mesohepatectomy. Am J Surg (2000) 1.13
Characterization of environmental regulators of Bordetella pertussis. Infect Immun (1993) 1.12
Oxidized low density lipoprotein inhibits macrophage apoptosis through activation of the PI 3-kinase/PKB pathway. J Lipid Res (2001) 1.11
Indications for liver transplantation in British Columbia's Aboriginal population: a 10-year retrospective analysis. Can J Gastroenterol (2000) 1.11
Autoantibodies to glucosylated proteins in the plasma of patients with diabetes mellitus. Proc Natl Acad Sci U S A (1984) 1.11
Genetic studies of the molecular basis of whooping cough. Dev Biol Stand (1985) 1.09
Neutralizing antibodies to adenylate cyclase toxin promote phagocytosis of Bordetella pertussis by human neutrophils. Infect Immun (2000) 1.09
Oxidized or acetylated low density lipoproteins are rapidly cleared by the liver in mice with disruption of the scavenger receptor class A type I/II gene. J Clin Invest (1997) 1.08
Bordetella avium virulence measured in vivo and in vitro. Infect Immun (1998) 1.07
Treating chronic hepatitis C with pegylated interferon alfa-2a (40 KD) and ribavirin in clinical practice. Aliment Pharmacol Ther (2006) 1.07
Inhibition of interleukin-12 and interferon-gamma production in immune cells by tanshinones from Salvia miltiorrhiza. Immunopharmacology (2000) 1.06
Bordetella extracytoplasmic adenylate cyclase: actions as a bacterial toxin. Dev Biol Stand (1985) 1.06
Oxidized low density lipoprotein is resistant to cathepsins and accumulates within macrophages. J Biol Chem (1991) 1.05
Secretions of the biliary mucosa in experimental clonorchiasis. Korean J Parasitol (1993) 1.05
Effects of oxidatively modified LDL on cholesterol esterification in cultured macrophages. J Lipid Res (1990) 1.03
Characterization of bactericidal immune responses following vaccination with acellular pertussis vaccines in adults. Infect Immun (2000) 1.03
Surgical management of choledochal cysts. Am J Surg (1994) 1.03
Phagocytosed Bordetella pertussis fails to survive in human neutrophils. Infect Immun (2000) 1.02
An independent and prospective comparison of two commercial fibrosis marker panels (HCV FibroSURE and FIBROSpect II) during albinterferon alfa-2b combination therapy for chronic hepatitis C. J Viral Hepat (2008) 1.02
Spontaneous sternal segment dislocation: a case report. J Pediatr Surg (1982) 1.02
A case report of inflammatory pseudotumor involving the clivus: CT and MR findings. Korean J Radiol (2001) 1.01
Obscure gastrointestinal bleeding from an ampullary tumour in a patient with a remote history of renal cell carcinoma: a diagnostic conundrum. Can J Gastroenterol (1998) 1.01
Hepatic hemangioblastoma. An unusual presentation in a patient with von Hippel-Lindau disease. Am J Surg Pathol (1991) 1.01
Adult hemoglobins are synthesized in murine fetal hepatic erythropoietic cells. Blood (1983) 1.01
Glucosylation of low-density lipoproteins to an extent comparable to that seen in diabetes slows their catabolism. Diabetes (1984) 1.01